Fexapotide TFA
Product Specifications
Target
Apoptosis
Related Pathways
Apoptosis
Bioactivity
Fexapotide (NX-1207) TFA selectively induces apoptosis, leading to a reduction in prostate volume at the cellular level. Fexapotide is applicable for research into lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) .
Molecular Formula
C90H163N27O25S.xC2HF3O2
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
